Literature DB >> 10756004

Chimeric matrix proteins encoded by defective proviruses with large internal deletions in human T-cell leukemia virus type 1-infected humans.

V A Morozov1, S Lagaye, G P Taylor, E Matutes, R A Weiss.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is the etiologic agent of adult T-cell leukemia/lymphoma (ATLL), HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), and other diseases. The mechanisms of virus pathogenesis are still obscure. The occurrence of defective proviruses in HTLV-1-infected cell lines and the peripheral blood mononuclear cells (PBMC) of infected individuals is a frequent feature of virus infection. We detected defective proviruses with large internal deletions in PBMC from ATLL and HAM/TSP patients and in asymptomatic HTLV-1 carriers. Seventeen PCR-amplified defective proviruses were sequenced, and three types of deletions were found. Besides truncated MA and the 5' end of the genome, truncated CA, truncated SU, and more frequently truncated TM linked to the pX region were detected. Reverse transcription-PCR analysis of PBMC from ATLL patients and asymptomatic carriers also revealed RNA transcripts with large internal deletions. Analysis of two RT-PCR cDNA clones confirmed a Gag-TM-pX structure of the transcripts. Most defective proviruses contained numerous internal stop codons, but some were capable of coding for the truncated MA linked to a variable out-of-frame peptide. Cloned defective proviruses with long open reading frames were subjected to in vitro transcription-translation followed by radioimmunoprecipitation, which showed expression of chimeric proteins between 8 and 12 kDa. Possible roles of defective proviruses and chimeric proteins are discussed, although there is no firm association with pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10756004      PMCID: PMC111906          DOI: 10.1128/jvi.74.9.3933-3940.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.

Authors:  M Shuh; S A Hill; D Derse
Journal:  Virology       Date:  1999-09-30       Impact factor: 3.616

2.  Comparisons of defective HTLV-I proviruses predict the mode of origin and coding potential of internally deleted genomes.

Authors:  S A Hill; M Shuh; D Derse
Journal:  Virology       Date:  1999-10-25       Impact factor: 3.616

3.  Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I.

Authors:  L Ratner; S F Josephs; B Starcich; B Hahn; G M Shaw; R C Gallo; F Wong-Staal
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

4.  Frequent partial deletion of human adult T-cell leukemia virus type I proviruses in experimental transmission: pattern and possible implication.

Authors:  K Hiramatsu; H Yoshikura
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

5.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

6.  Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera.

Authors:  P Clapham; K Nagy; R A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

7.  A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; Y Shiraishi
Journal:  Gan       Date:  1981-12

8.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

9.  Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.

Authors:  M Seiki; S Hattori; Y Hirayama; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Genomic structure of HTLV (human T-cell leukemia virus): detection of defective genome and its amplification in MT-2 cells.

Authors:  N Kobayashi; H Konishi; H Sabe; K Shigesada; T Noma; T Honjo; M Hatanaka
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

View more
  5 in total

1.  Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2.

Authors:  Charlene S Dezzutti; Patricia C Guenthner; Sylvester Daniel; Ursula Utz; Thania Cabrera; James H Marshall; Celso Bianco; Renu B Lal; Elliot P Cowan
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

2.  An overview of sequencing technology platforms applied to HTLV-1 studies: a systematic review.

Authors:  Felipe de Oliveira Andrade; Marina Silveira Cucco; Melina Mosquera Navarro Borba; Reinaldo Conceição Neto; Luana Leandro Gois; Filipe Ferreira de Almeida Rego; Luciane Amorim Santos; Fernanda Khouri Barreto
Journal:  Arch Virol       Date:  2021-08-20       Impact factor: 2.574

Review 3.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

Review 4.  Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma.

Authors:  G Taylor
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

5.  Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors.

Authors:  Beatrice Macchi; Emanuela Balestrieri; Arianna Ascolani; Silva Hilburn; Fabiola Martin; Antonio Mastino; Graham P Taylor
Journal:  Viruses       Date:  2011-05-05       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.